secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001193125-23-245768
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam director Marsha H. Fanucci resigns; Peter N. Kellogg named Audit Chair
------------------------------------------------------------------------------

- Marsha H. Fanucci resigned from Board effective Sept 29, 2023; no disagreement with company.
- Peter N. Kellogg appointed Chair of Audit Committee; qualifies as audit committee financial expert.
- Board size reduced from 13 to 12 members effective upon Fanucci's resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/0001193125-23-245768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523245768/d477237d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-245768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer